Ting-Hui Lin

5PUBLICATIONS
73CO-AUTHORS
Medical virologyAnimal protection (incl. pests and pathogens)Innate immunityCheminformatics and quantitative structure-activity relationshipsCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 15, 2025
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.

María Ríos Carrasco, Ting-Hui Lin, Xueyong Zhu

|Dec 05, 2024
A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors.

Ting-Hui Lin, Xueyong Zhu, Shengyang Wang

|Jun 27, 2024
Maturation of germinal center B cells after influenza virus vaccination in humans.

Katherine M McIntire, Hailong Meng, Ting-Hui Lin

|May 16, 2024
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.

Seiya Kitamura, Ting-Hui Lin, Chang-Chun David Lee

|Jul 20, 2022
Broadly neutralizing antibodies target the coronavirus fusion peptide.

Cherrelle Dacon, Courtney Tucker, Linghang Peng

Pageof 1

Frequent Collaborators

5 joint publications

Ian A Wilson

3 joint publications

Xueyong Zhu

2 joint publications

Wenli Yu

2 joint publications

Chang-Chun David Lee